Copyright
©The Author(s) 2016.
World J Gastroenterol. May 7, 2016; 22(17): 4373-4379
Published online May 7, 2016. doi: 10.3748/wjg.v22.i17.4373
Published online May 7, 2016. doi: 10.3748/wjg.v22.i17.4373
Age mean (range) | 65.7 (34-82) |
Men/women | 33/24 |
HBsAg positivity | 10 (1.6) |
HCV positivity | 7 (1.2) |
Diagnosis | |
HCC | 26 (45.6) |
Hilar cholangiocarcinoma | 12 (21.1) |
Intrahepatic cholangiocarcinoma | 6 (10.5) |
Metastatic tumor | 4 (7.0) |
Hemangioma | 4 (7.0) |
Others | 5 (8.8) |
Child-Pugh score (5/6/7/8) | 44/8/3/2 |
Child-Pugh classification (A/B) | 52/5 |
ICGR15, mean (range) | 10.8 (1.5-44.3) |
LHL15, mean (range) | 0.920 (0.712-0.973) |
Preoperative therapies | 18 (31.6) |
TACE | 6 (10.5) |
Radiation | 5 (8.8) |
RFA | 3 (5.3) |
Partial resection | 3 (5.3) |
Chemotherapy | 1 (1.8) |
Tumor size > 1000 mL | 5 (8.8) |
Portal vein thrombosis | 8 (14.0) |
Hepatic vein thrombosis | 3 (5.3) |
Preoperative biliary drainage | 15 (26.3) |
Preoperative portal vein embolization | 13 (22.8) |
- Citation: Tsuruga Y, Kamiyama T, Kamachi H, Shimada S, Wakayama K, Orimo T, Kakisaka T, Yokoo H, Taketomi A. Significance of functional hepatic resection rate calculated using 3D CT/99mTc-galactosyl human serum albumin single-photon emission computed tomography fusion imaging. World J Gastroenterol 2016; 22(17): 4373-4379
- URL: https://www.wjgnet.com/1007-9327/full/v22/i17/4373.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i17.4373